Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.67 AUD | -1.54% | -2.64% | -7.49% |
May. 17 | Australia shares retreat as banks, technology, healthcare stocks drag | RE |
May. 16 | Australia shares jump as US inflation data reinforces rate-cut hopes | RE |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
Weaknesses
- The company does not generate enough profits, which is an alarming weak point.
- The company is in debt and has limited leeway for investment
- The company benefits from high valuations in earnings multiples.
- The company is highly valued given the cash flows generated by its activity.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.49% | 7.38B | A- | ||
-22.44% | 15.75B | B+ | ||
+3.60% | 12.47B | B | ||
+3.98% | 11.73B | B+ | ||
+3.69% | 10.24B | B+ | ||
+26.63% | 8.51B | B | ||
+7.08% | 6.78B | B- | ||
+4.83% | 6.25B | D | ||
-3.14% | 4.33B | - | ||
+10.21% | 4.2B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- RHC Stock
- Ratings Ramsay Health Care Limited